Cryoablation Combined With Anti-PD-1 Antibody in Patients With Advanced Intrahepatic Cholangiocarcinoma
Status:
Recruiting
Trial end date:
2023-05-10
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of cryoablation combined
with anti-pd-1 antibody in patients with advanced hepatocellular carcinoma after progression
on first line systemic therapy.